Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCT1050210014
JPRN-jRCT1050210014
Recruiting
未知

Analyzing the impact of aging on the immune system in the context of covid-19 vaccination

Hamazaki Yoko0 sites200 target enrollmentMay 6, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCOVID-19

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19
Sponsor
Hamazaki Yoko
Enrollment
200
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 6, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
Hamazaki Yoko

Eligibility Criteria

Inclusion Criteria

  • •1\) Subjects working at Kyoto University and aged 20 years old or older at informed consent with no major medical history and other medical problems
  • •2\) Subjects aged 65 years old or older at informed consent with no major medical history
  • •3\) Subjects who have obtained written consent voluntarily to participate in this trial
  • •4\) Subjects who are scheduled to receive COVID\-19 vaccination

Exclusion Criteria

  • •1\) Subjects who have been administered with drugs that affect the immune system (excluding external preparations) such as immunomodulators (DMARDs, etc.), immunosuppressants, biologics, etc.
  • •2\) Subjects who are tested positive for human immunodeficiency virus (HIV), hepatitis C virus (HCV), hepatitis B virus (HBV), or HTLV\-1\.
  • •3\) Subjects who are otherwise ineligible for this study in the principal investigator's or subinvestigator's opinion.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Age-related changes of the immune system leading to hyporesponsiveness; a major player and predictor for biological behaviour of metastasized melanoma?metastasized melanomaskin cancer10040900
NL-OMON43667niversitair Medisch Centrum Groningen30
Recruiting
Not Applicable
De rol van veroudering van het immuunsysteem bij het melanoom.
NL-OMON22761MCG30
Completed
Not Applicable
Immune ageing in health and diseasegezonde veroudering en ongezonde veroudering/frailtyageing and frailty
NL-OMON39532niversitair Medisch Centrum Groningen300
Completed
Not Applicable
Elderly Influenza Vaccine Immunogenicity SubstudyInfluenza
NCT00170482National Institute of Allergy and Infectious Diseases (NIAID)60
Unknown
Not Applicable
PRIMAGE (Probiotics, Immunity and Ageing)Influenza
NCT01066377University of Reading120